Global malaria crisis worsens as US aid cuts, rising resistance, and stalled progress put millions, especially children, at deadly risk.
You must be a subscriber to access all of this content.
Dis-Chem's personalised healthcare model uses AI and data to offer tailored care, rewards, and insurance - reshaping retail pharmacy.
You must be a subscriber to access all of this content.
Aspen APAC divestment unlocks R26.5bn in capital, sharpening the group’s focus on GLP-1 injectables and reducing net debt heading into 2026.
You must be a subscriber to access all of this content.
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
You must be a subscriber to access all of this content.
America First health funding plan faces legal challenges in Kenya over privacy, even as Uganda secures $1.7B with new co-financing model.
You must be a subscriber to access all of this content.